Vascularisation in Deep Endometriosis: A Systematic Review with Narrative Outcomes
Cells · 05.05.2023 · 12 (9) · 1318
DOI: 10.3390/cells12091318 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cells, online erschienen am 05.05.2023. Verfasst von Simon G Powell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, Institute of Life Course and Medical Science, University of Liverpool, Liverpool L8 7SS, UK. Hauptthemen laut MEDLINE: Endometriosis. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Liverpool University Hospital, Wellbeing of Women.
Abstract (Originalsprache)
Deep endometriosis (DE) is the most severe subtype of endometriosis, with the hallmark of lesions infiltrating adjacent tissue. Abnormal vascularisation has been implicated in contributing to endometriosis lesion development in general, and how vascularisation influences the pathogenesis of DE, in particular, is of interest. This systematic review followed the PRISMA guidelines to elucidate and examine the evidence for DE-specific vascularisation. A literature search was performed using MEDLINE, Embase, PubMed, Scopus, Cochrane CENTRAL Library and Europe PubMed Central databases. The databases were searched from inception to the 13 March 2023. A total of 15 studies with 1125 patients were included in the review. The DE lesions were highly vascularised, with a higher microvessel density (MVD) than other types of endometriotic lesions, eutopic endometrium from women with endometriosis and control tissue. Vascular endothelial growth factor, its major subtype (VEGF-A) and associated receptor (VEGFR-2) were significantly increased in the DE lesions compared to superficial endometriosis, eutopic endometrium and control tissue. Progestin therapy was associated with a significant decrease in the MVD of the DE lesions, explaining their therapeutic effect. This review comprehensively summarises the available literature, reporting abnormal vascularisation to be intimately related to the pathogenesis of DE and presents potentially preferential therapeutic targets for the medical management of DE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Women's and Children's Health, Institute of Life Course and Medical Science, University of Liverpool, Liverpool L8 7SS, UK.
- Liverpool Women's Hospital NHS Foundation Trust, Liverpool L8 7SS, UK.
- Liverpool University Hospitals NHS Foundation Trust, Liverpool L7 8XP, UK.
- School of Medicine, University of Liverpool, Liverpool L8 7SS, UK.
- Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510180, China.
- Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 3GE, UK.
ORCID-Profile: Simon G Powell, Gendie Lash, Dharani K Hapangama
Förderung
- Royal Liverpool University Hospital
- Wellbeing of Women
Zitieren
APA
Powell, S. G., Sharma, P., Masterson, S., Wyatt, J., Arshad, I., Ahmed, S., Lash, G., Cross, M., & Hapangama, D. K. (2023). Vascularisation in Deep Endometriosis: A Systematic Review with Narrative Outcomes. Cells, 12(9), 1318. https://doi.org/10.3390/cells12091318
Vancouver
Powell SG, Sharma P, Masterson S, Wyatt J, Arshad I, Ahmed S, et al. Vascularisation in Deep Endometriosis: A Systematic Review with Narrative Outcomes. Cells. 2023;12(9):1318. doi:10.3390/cells12091318
BibTeX
@article{Powell2023,
author = {Powell, Simon G and Sharma, Priyanka and Masterson, Samuel and Wyatt, James and Arshad, Ilyas and Ahmed, Shakil and Lash, Gendie and Cross, Michael and Hapangama, Dharani K},
title = {Vascularisation in Deep Endometriosis: A Systematic Review with Narrative Outcomes},
journal = {Cells},
year = {2023},
volume = {12},
number = {9},
pages = {1318},
doi = {10.3390/cells12091318}
}
EUVIMED